Sermorelin: the GHRH(1-29) analogue

Sermorelin is a GHRH analogue frequently studied alongside other growth-hormone secretagogues. This overview describes its structure and handling, with no therapeutic or dosing claims.

What it is

Sermorelin corresponds to the first 29 amino acids of growth-hormone-releasing hormone — the fragment GHRH(1-29) that retains the activity of the full hormone. It is a member of the GHRH-analogue branch of the secretagogue family.

Why it is studied

Sermorelin appears in preclinical and in-vitro literature exploring the GHRH pathway. For how GHRH analogues relate to ghrelin-receptor agonists, see our growth-hormone-secretagogues overview.

Handling notes

• Supplied lyophilised; reconstitute gently without shaking.
• Keep the dry solid sealed, cold and dark.
• Refrigerate after reconstitution and aliquot for repeated use.

For in-vitro research use only. Not for human or veterinary use.